Benutzer: Gast  Login
Dokumenttyp:
Journal Article; Research Support, Non-U.S. Gov't; Article
Autor(en):
Borel, P; Benkhoucha, M; Weber, MS; Zamvil, SS; Santiago-Raber, ML; Lalive, PH
Titel:
Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
Abstract:
Glatiramer acetate (GA, copolymer-1, Copaxone), a therapy approved for treatment of multiple sclerosis (MS), prevents and reverses experimental autoimmune encephalomyelitis, the animal model of MS. In central nervous system autoimmune disease, GA is thought to act through modulation of antigen-presenting cells, such as monocytes, mediating an antigen-independent T(h)2 shift and development of FoxP3+ regulatory T cells. Recent reports indicate that GA may also be effective in models of other auto...     »
Zeitschriftentitel:
Int Immunol
Jahr:
2008
Band / Volume:
20
Heft / Issue:
10
Seitenangaben Beitrag:
1313-9
Sprache:
eng
Volltext / DOI:
doi:10.1093/intimm/dxn086
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/18687587
Print-ISSN:
0953-8178
TUM Einrichtung:
Neurologische Klinik und Poliklinik
 BibTeX